| Absorption |
| Blood-Brain Barrier | BBB- | 0.9770 |
| Human Intestinal Absorption | HIA+ | 0.7103 |
| Caco-2 Permeability | Caco2- | 0.7679 |
| P-glycoprotein Substrate | Substrate | 0.6678 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9246 |
| Non-inhibitor | 0.8160 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8575 |
| Distribution |
| Subcellular localization | Mitochondria | 0.3519 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8377 |
| CYP450 2D6 Substrate | Non-substrate | 0.8186 |
| CYP450 3A4 Substrate | Non-substrate | 0.5444 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7647 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8032 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8830 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7752 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7738 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8934 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9750 |
| Non-inhibitor | 0.8604 |
| AMES Toxicity | Non AMES toxic | 0.8443 |
| Carcinogens | Non-carcinogens | 0.8778 |
| Fish Toxicity | High FHMT | 0.9110 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8989 |
| Honey Bee Toxicity | Low HBT | 0.6074 |
| Biodegradation | Not ready biodegradable | 0.9891 |
| Acute Oral Toxicity | IV | 0.5407 |
| Carcinogenicity (Three-class) | Non-required | 0.5125 |